Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$8.51 USD
-0.51 (-5.65%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $8.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Detailed Estimates
Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | 0.19 |
EPS Last Quarter | 0.00 |
Last EPS Surprise | -100.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.70 |
Next Year | 0.86 |
EPS (TTM) | 0.68 |
P/E (F1) | 12.84 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 103.20M | 111.67M | 445.41M | 486.56M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 104.00M | 114.50M | 451.20M | 518.00M |
Low Estimate | 102.10M | 109.00M | 436.00M | 470.80M |
Year ago Sales | 104.06M | 107.38M | 442.73M | 445.41M |
Year over Year Growth Est. | -0.83% | 3.99% | 0.60% | 9.24% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.19 | 0.23 | 0.70 | 0.86 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | 0.18 | 0.21 | 0.65 | 0.87 |
High Estimate | 0.29 | 0.31 | 0.89 | 0.95 |
Low Estimate | 0.11 | 0.16 | 0.59 | 0.76 |
Year ago EPS | 0.25 | 0.31 | -6.27 | 0.70 |
Year over Year Growth Est. | -24.00% | -25.81% | 111.16% | 22.14% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 3 | 2 | 4 |
Down Last 60 Days | 2 | 3 | 2 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.19 | 0.23 | 0.70 | 0.86 |
7 Days Ago | 0.19 | 0.23 | 0.70 | 0.86 |
30 Days Ago | 0.27 | 0.27 | 0.79 | 1.11 |
60 Days Ago | 0.27 | 0.27 | 0.72 | 1.11 |
90 Days Ago | 0.27 | 0.27 | 0.66 | 1.11 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.19 | 0.23 | 0.70 | 0.86 |
Zacks Consensus Estimate | 0.19 | 0.23 | 0.70 | 0.86 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.00 | 0.12 | 0.31 | 0.25 | NA |
Estimate | 0.20 | 0.17 | 0.25 | 0.24 | NA |
Difference | -0.20 | -0.05 | 0.06 | 0.01 | -0.05 |
Surprise | -100.00% | -29.41% | 24.00% | 4.17% | -25.31% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more